CorVel Corp CEO and President Sarah A. Scott was awarded 12,000 non-qualified stock options at an exercise price of $85.91 per share, according to a beneficial ownership statement filed with the SEC on November 9, 2026, covering a transaction dated November 5, 2026.

Key Highlights

  • Reporting person: Sarah A. Scott, CEO and President of CorVel Corp (NASDAQ:CRVL)
  • Security awarded: Non-Qualified Stock Option (right to buy) on Common Stock
  • Options granted: 12,000 shares acquired (transaction code A) on November 5, 2026
  • Exercise price: $85.91 per share, with a stated price of $0.0 for the derivative security itself
  • Expiration date: November 5, 2031
  • Vesting condition: Options vest based on achievement of certain performance criteria relating to earnings growth, per the filing's footnote
  • Post-transaction holdings: 12,000 derivative securities beneficially owned following the reported transaction, held directly

CorVel Corp CEO Awarded Performance-Based Options in November 2026

According to the filing, Sarah A. Scott, who serves as CEO and President of CorVel Corp, received a grant of 12,000 non-qualified stock options on November 5, 2026. The options carry an exercise price of $85.91 per share and are exercisable on the underlying Common Stock of CorVel Corp. The stated price of the derivative security at the time of the award was $0.0, as reported in the filing. CorVel Corp is a managed care services company listed on NASDAQ under the ticker CRVL.

The filing notes that the options will expire on November 5, 2031, giving the award a five-year term from the date of grant. As described in the footnote to the filing, "Option will vest based on achievement of certain performance criteria relating to earnings growth." Following this transaction, Scott is reported to beneficially own 12,000 derivative securities directly. The statement was signed by Sharon O'Connor on behalf of Sarah Scott and filed on November 9, 2026.

What Was Disclosed

CorVel Corp's CEO and President Sarah A. Scott acquired 12,000 non-qualified stock options at an exercise price of $85.91 per share on November 5, 2026. The options expire November 5, 2031, and vest subject to performance criteria tied to earnings growth, as stated in the filing.